/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
McKesson Corporation (MCK), headquartered in Irving, Texas, provides healthcare services to advance patients' health outcomes. Valued at $76.69 billion by market cap, the company distributes branded and generic pharmaceutical drugs and other healthcare-related products and provides practice management, technology, clinical support, and business solutions. It offers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions.
Companies worth $10 billion or more are generally described as “large-cap stocks,” MCK fits right into that category, signifying its substantial size, stability, and dominance in its industry. The company partners with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services to make quality healthcare accessible and affordable.